Terms: = Liver cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Prognosis
65 results:
1. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract] [Full Text] [Related]
2. Intratumoral cxcr4
Lu Z; Wang X; Feng J; Chai W; Wang W; Wang Q; Yang S; Yang W; Su Y; Mou W; Peng Y; Wang H; Gui J
Front Immunol; 2024; 15():1363454. PubMed ID: 38487536
[TBL] [Abstract] [Full Text] [Related]
3. Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation.
Zhu JQ; Zhu Y; Qi M; Zeng Y; Liu ZJ; Ding C; Zhang T; Li XL; Han DD; He Q
Cancer Immunol Immunother; 2024 Feb; 73(3):58. PubMed ID: 38386050
[TBL] [Abstract] [Full Text] [Related]
4. Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization.
Pei W; Wei K; Wu Y; Qiu Q; Zhu H; Mao L; Shi X; Zhang S; Shi Y; Tao S; Mao H; Pang S; Wang J; Liu M; Wang W; Yang Q; Chen C
Gene; 2023 Nov; 885():147692. PubMed ID: 37562585
[TBL] [Abstract] [Full Text] [Related]
5. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract] [Full Text] [Related]
6. cxcr4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12/cxcr4 signaling axis in preclinical breast cancer model.
Gupta N; Mohan CD; Shanmugam MK; Jung YY; Chinnathambi A; Alharbi SA; Ashrafizadeh M; Mahale M; Bender A; Kumar AP; Putti TC; Rangappa KS; Zhang X; Ahn KS; Sethi G
Environ Res; 2023 Sep; 232():116335. PubMed ID: 37290620
[TBL] [Abstract] [Full Text] [Related]
7. In vivo validation of
Renard I; Domarkas J; Poty S; Burke BP; Roberts DP; Goze C; Denat F; Cawthorne CJ; Archibald SJ
Nucl Med Biol; 2023; 120-121():108335. PubMed ID: 37068392
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Mechanism of Integrin αvβ6 in liver Metastasis of Colon cancer Based on SDF-1/cxcr4.
Shi J; Fan L; Li B; Pan H
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):88-95. PubMed ID: 35818267
[TBL] [Abstract] [Full Text] [Related]
9. High ratio of pcxcr4/cxcr4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy.
Walther F; Berther JL; Lalos A; Ramser M; Eichelberger S; Mechera R; Soysal S; Muenst S; Posabella A; Güth U; Stadlmann S; Terracciano L; Droeser RA; Zeindler J; Singer G
BMC Cancer; 2022 Apr; 22(1):376. PubMed ID: 35397601
[TBL] [Abstract] [Full Text] [Related]
10. cxcr4 promotes gefitinib resistance of Huh7 cells by activating the c-Met signaling pathway.
Zhao D; Yang Z; Chen C; Zhang Z; Yu Y; Li Z
FEBS Open Bio; 2021 Nov; 11(11):3115-3125. PubMed ID: 34555268
[TBL] [Abstract] [Full Text] [Related]
11. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.
Correia AL; Guimaraes JC; Auf der Maur P; De Silva D; Trefny MP; Okamoto R; Bruno S; Schmidt A; Mertz K; Volkmann K; Terracciano L; Zippelius A; Vetter M; Kurzeder C; Weber WP; Bentires-Alj M
Nature; 2021 Jun; 594(7864):566-571. PubMed ID: 34079127
[TBL] [Abstract] [Full Text] [Related]
12. Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing cxcr4.
Pallarès V; Núñez Y; Sánchez-García L; Falgàs A; Serna N; Unzueta U; Gallardo A; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
J Control Release; 2021 Jul; 335():117-129. PubMed ID: 34004204
[TBL] [Abstract] [Full Text] [Related]
13. 7-Hydorxyindirubin is capable of specifically inhibiting anticancer drug-induced YB-1 nuclear translocation without showing cytotoxicity in HepG2 hepatocellular carcinoma cells.
Tanaka T; Saito H; Miyairi S; Kobayashi S
Biochem Biophys Res Commun; 2021 Mar; 544():15-21. PubMed ID: 33516877
[TBL] [Abstract] [Full Text] [Related]
14. CXCL12-mediated HOXB5 overexpression facilitates Colorectal cancer metastasis through transactivating cxcr4 and ITGB3.
Feng W; Huang W; Chen J; Qiao C; Liu D; Ji X; Xie M; Zhang T; Wang Y; Sun M; Tian D; Fan D; Nie Y; Wu K; Xia L
Theranostics; 2021; 11(6):2612-2633. PubMed ID: 33456563
[No Abstract] [Full Text] [Related]
15.
Vallejo-Armenta P; Santos-Cuevas C; Soto-Andonaegui J; Villanueva-Pérez RM; González-Díaz JI; García-Pérez FO; Arrellano-Zarate A; Luna-Gutiérrez M; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
Contrast Media Mol Imaging; 2020; 2020():2525037. PubMed ID: 32410920
[TBL] [Abstract] [Full Text] [Related]
16. SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.
Tsai CN; Yu SC; Lee CW; Pang JS; Wu CH; Lin SE; Chung YH; Tsai CL; Hsieh SY; Yu MC
Oncogene; 2020 Jun; 39(24):4695-4710. PubMed ID: 32404985
[TBL] [Abstract] [Full Text] [Related]
17. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract] [Full Text] [Related]
19. Effect of CXCL12 and Its Receptors on Unpredictable Renal Cell Carcinoma.
Floranović MP; Veličković LJ
Clin Genitourin Cancer; 2020 Aug; 18(4):e337-e342. PubMed ID: 31882334
[TBL] [Abstract] [Full Text] [Related]
20. cxcr4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
[No Abstract] [Full Text] [Related]
[Next]
